Germline Genetic Contributions to Risk for Esophageal Adenocarcinoma, Barrett's Esophagus, and Gastroesophageal Reflux

Bernstein, L.; Bird, N. C.; Bresso, F.; Casson, A. G.; Chow, W.-H.; Corley, D. A.; D'Amato, M.; Ek, W. E.; Gammon, M. D.; Hardie, L. J.; Hysi, P.; Levine, D. M.; Liu, G.; MacGregor, S.; Magnusson, P. K. E.; Murray, L. J.; Nordenstedt, H.; Onstad, L. E.; Pedersen, N. L.; Reid, B. J.; Risch, H. A.; Romero, Y.; Schmidt, P. T.; Shaheen, N. J.; Spector, T. D.; Tornblom, H.; Vaughan, T. L.; Whiteman, D. C.; Wu, A. H.; Ye, W.; Zucchelli, M.

Germline Genetic Contributions to Risk for Esophageal Adenocarcinoma, Barrett's Esophagus, and Gastroesophageal Reflux

Abstract

Esophageal adenocarcinoma (EA) is an increasingly common cancer with poor survival. Barrett’s esophagus (BE) is the main precursor to EA, and every year 0.12% to 0.5% of BE patients progress to EA. BE typically arises on a background of chronic gastroesophageal reflux (GERD), one of the risk factors for EA

Similar works

Full text

Open in the Core reader

Download PDF

Available Versions

Carolina Digital Repository

cdr.lib.unc.edu:2801pp89r

Last time updated on 24/11/2020